FDA Investigator

Elyshia Q Danaher

Latest inspection on record: Channelview, United States, June 2026 · records back to 2024

Biologics

FDA inspection record · Last updated August 15, 2026

Overview

  • 53 inspections across 53 sites are on record.
  • 39 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-30.

At a glance

Inspections

53

Sites

53

Observations

39

Career since

Mar 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Biomat USA Inc30 Jun 2026Biologics
Texas Children's Hospital Blood Bank11 Jun 2026Biologics
Michael A. Allon, M.D, P.A.1 Jun 2026BiologicsView 483 →
18HHS LLC1 Jun 2026BiologicsView 483 →
Oklahoma Blood Institute Southern12 May 2026Biologics

Sites inspected

Biomat USA IncChannelview, United States1 insp.
Texas Children's Hospital Blood BankHouston, United States1 insp.
Michael A. Allon, M.D, P.A.Houston, United States1 insp.
18HHS LLCHouston, United States1 insp.
Oklahoma Blood Institute SouthernArdmore, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Ashleigh M Robertson6 shared
John A Iwen3 shared

Full investigator report

Get the verbatim findings behind Elyshia Q Danaher's 39 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site